The methylation was discovered in 9 of 36 (25%) FIGO stage I~II and in 22 of 43 (51.16%) FIGO stage III~IV; Wnt5a was methylated in 21 of 41 (51.22%) carcinomas with lymph node metastasis, while 10 of 28 (26.32%) tumors without lymph node metastasis. Here, WNT5A is linked to carcinoma.